JP2024518370A5 - - Google Patents
Info
- Publication number
- JP2024518370A5 JP2024518370A5 JP2023567201A JP2023567201A JP2024518370A5 JP 2024518370 A5 JP2024518370 A5 JP 2024518370A5 JP 2023567201 A JP2023567201 A JP 2023567201A JP 2023567201 A JP2023567201 A JP 2023567201A JP 2024518370 A5 JP2024518370 A5 JP 2024518370A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- airway collapse
- pharyngeal airway
- condition associated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| USPCT/US2021/030571 | 2021-05-04 | ||
| PCT/US2021/030571 WO2021226020A1 (en) | 2020-05-05 | 2021-05-04 | Polymorphic forms of (r)-oxybutynin hydrochloride |
| US202163248684P | 2021-09-27 | 2021-09-27 | |
| US63/248,684 | 2021-09-27 | ||
| PCT/US2022/027573 WO2022235726A1 (en) | 2021-05-04 | 2022-05-04 | Solid forms of (r)-oxybutynin d-malate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024518370A JP2024518370A (ja) | 2024-05-01 |
| JP2024518370A5 true JP2024518370A5 (enExample) | 2025-05-21 |
Family
ID=81654984
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023567201A Pending JP2024518370A (ja) | 2021-05-04 | 2022-05-04 | （ｒ）－オキシブチニンｄ－リンゴ酸塩の固体形態 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240217918A1 (enExample) |
| EP (1) | EP4334281A1 (enExample) |
| JP (1) | JP2024518370A (enExample) |
| KR (1) | KR20240004600A (enExample) |
| AU (1) | AU2022270639A1 (enExample) |
| CA (1) | CA3215373A1 (enExample) |
| WO (1) | WO2022235726A1 (enExample) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| WO2009122429A2 (en) * | 2008-02-04 | 2009-10-08 | Matrix Laboratories Limited | Crystalline oxybutynin and process for preparing the same |
| CN104370760B (zh) * | 2013-11-29 | 2016-06-01 | 江苏汉邦科技有限公司 | 模拟移动床色谱拆分奥昔布宁对映体的方法 |
| KR102874891B1 (ko) | 2018-01-30 | 2025-10-21 | 애프니메드, 인코포레이티드 (델라웨어) | 수면 무호흡증을 치료하기 위한 방법 및 조성물 |
-
2022
- 2022-05-04 EP EP22723937.3A patent/EP4334281A1/en active Pending
- 2022-05-04 WO PCT/US2022/027573 patent/WO2022235726A1/en not_active Ceased
- 2022-05-04 KR KR1020237040419A patent/KR20240004600A/ko active Pending
- 2022-05-04 CA CA3215373A patent/CA3215373A1/en active Pending
- 2022-05-04 JP JP2023567201A patent/JP2024518370A/ja active Pending
- 2022-05-04 US US18/289,126 patent/US20240217918A1/en active Pending
- 2022-05-04 AU AU2022270639A patent/AU2022270639A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Michels et al. | Nasal involvement in obstructive sleep apnea syndrome | |
| Georgalas | The role of the nose in snoring and obstructive sleep apnoea: an update | |
| Joseph et al. | High-flow nasal cannula therapy for obstructive sleep apnea in children | |
| JP2023076465A5 (enExample) | ||
| FI3746126T3 (fi) | Menetelmiä ja koostumuksia uniapnean tai pelkän kuorsauksen hoitamiseksi | |
| JP2023545372A5 (enExample) | ||
| Tserenpil et al. | Managements for obstructive sleep apnea in adults | |
| JP2024518370A5 (enExample) | ||
| Kim et al. | Drug Induced Sleep Endoscopy for Poor-Responder to Uvulopalatopharyngoplasty in Patient with Obstructive Sleep Apnea Patients. | |
| CN107510713A (zh) | 一种能够减轻或消除打鼾症状的液体止鼾器的配方及其制备方法 | |
| JP2010523662A5 (enExample) | ||
| JP2008542443A5 (enExample) | ||
| JP2024523876A5 (enExample) | ||
| Starovoytova | Snoring and its-management (Part 1/2): A Review | |
| WO2004034973A3 (en) | Method of treating snoring and other obstructive breathing disorders | |
| Baby et al. | Therapeutic options for obstructive sleep apnea | |
| Verse et al. | Sleep Disorders and the Nose: What Is the Evidence Base? | |
| Çiftçi | Positive Airway Pressure Treatment for Sleep Apnea | |
| RU2024117463A (ru) | Способ лечения синдрома обструктивного апноэ сна (СОАС) | |
| Cherchi | Fluticasone and Azelastine | |
| CN309718188S (zh) | 睡眠呼吸暂停电刺激仪 | |
| Min et al. | Medical management of obstructive sleep apnea | |
| Jung et al. | Massive REM Rebound on Continuous Positive Airway Pressure in Obstructive Sleep Apnea | |
| Rossini | Obstructive Sleep Apnea and Obesity | |
| Moon | Medical Treatment of Sleep Disordered Breathing |